Webb17 maj 2024 · Today, Philip Morris International Inc. (PMI) (NYSE: PM) released its third annual Integrated Report, which includes an updated Statement of Purpose, a new environmental, social, and governance (ESG) framework, as well as detailed information about PMI’s strategic vision, performance, governance, and value creation model. The … Webb30 mars 2024 · Phillip Morris ( PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. The treatment is meant to assist the more than 83 million Americans at risk of myocardial infarction.
Philip Morris International acquires inhaled drug …
Webb9 aug. 2024 · Philip Morris International Inc (NYSE: PM) has acquired OtiTopic, a U.S. respiratory drug development company, for an undisclosed sum. OtiTopic has late-stage … Webb19 aug. 2024 · Philip Morris International continues its push into drug delivery with the acquisition of OtiTopic, a Los Angeles–based specialist in inhaled drugs. OtiTopic has … how is the weather in oregon
Philip Morris International Acquires Inhaled Drug Specialist OtiTopic …
Webb9 aug. 2024 · LAUSANNE, Switzerland-- ( BUSINESS WIRE )--Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug … Webb9 aug. 2024 · OtiTopic was founded in 2012 as an innovative pharmaceutical start-up company and holds several key patents, differentiated intellectual property, and has confirmed a 505(b)2 pathway through constructive interactions with the FDA. PMI expects the impact of the acquisition of OtiTopic on its full-year 2024 adjusted diluted EPS to be … Webb9 aug. 2024 · LAUSANNE, Switzerland -- (BUSINESS WIRE)--Aug. 9, 2024-- Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. … how is the weather in paris france